Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

ConferenceMRD TestingPositive

AI Analysis

Summary

Adaptive Biotechnologies highlighted the role of highly sensitive MRD testing in the new International Myeloma Society consensus definition of cure for multiple myeloma, presented at the IMS 23rd Annual Meeting.

Importance:4/10

Sentiment:

0.50

myelomaMRD testingconsensus definitiondiagnostic

Related Companies

$ADPT $ISCO

Read the original article

Published by GlobeNewswire Clinical Studies on September 25, 2026 12:03 PM

Read Original